🇺🇸 FDA
Patent

US 11312962

Modulators of diacyglycerol acyltransferase 2 (DGAT2)

granted A61PA61P1/16

Quick answer

US patent 11312962 (Modulators of diacyglycerol acyltransferase 2 (DGAT2)) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P1/16